96 results on '"Calvo, V"'
Search Results
2. P1.22-16 ERBB3 and BRAF Mutations as Potential Biomarkers in Non-Small Cell Lung Cancer Patients Under Immunotherapy-Based Treatments
3. EP08.03-01 Copy Number Variants and Late Somatic Mutations Underlying Tumor Progression in NADIM Clinical Trials
4. The aqueous processing of carbon nanofibers via cellulose nanocrystals as a green path towards e-textiles with n-type thermoelectric behaviour
5. MA03.11 Big Data and Artificial Intelligence for Exploring the Role of Genetic Risk. Family History of Cancer and Lung Cancer. Results from CLARIFY
6. P1.27-07 BRAF Mutations Identify Non-small-Cell Lung Cancer Patients Who Benefit from Neoadjuvant Chemo-Immunotherapy
7. P2.31-12 Sexual Dysfunction on Patients with Lung Cancer: Results from the CLARIFY Project
8. PL03.12 Progression Free Survival and Overall Survival in NADIM II Study
9. OA02.03 Tumor Bulk-RNA Seq Identifies Patients at High Risk of Progression in Non-complete Pathological Responders from NADIM Trial
10. EP06.01-017 Clinical Impact of SARS-CoV2 Pandemic in the Diagnosis of Early-Stage Thoracic Tumours
11. MA06.03 Pre-treatment ctDNA Levels Significantly Predicts of OS and PFS in NADIM II Trial
12. EP13.01-016 Are Follow-up Tests Useful in NSCLC? Experience of a Tertiary Hospital
13. EP16.02-007 Detection of Clinically Relevant Fusions and Exon Skipping Alterations in Non Small Cell Lung Cancer Patients Liquid Biopsies
14. Paraparesia tras embolización de saco aneurismático de aorta abdominal
15. Paraparesis after embolization of abdominal aortic aneurysm sac
16. KRAS p.G12C mutation occurs in 1% of EGFR-mutated advanced non-small-cell lung cancer patients progressing on a first-line treatment with a tyrosine kinase inhibitor
17. OA20.02 Pre-Treatment Levels of ctDNA for Long-Term Survival Prediction in Stage IIIA NSCLC Treated With Neoadjuvant Chemo-Immunotherapy
18. P40.12 Cardiotoxicity in Lung Cancer Patients Treated With Immune-Checkpoints Inhibitors
19. OA14.01 Family History of Cancer and Lung Cancer: Information from the Thoracic Tumors Registry (TTR Study)
20. P31.02 Impact of COVID-19 Pandemic in Spanish and Portuguese Lung Cancer Patients
21. P08.01 Building Personalized Follow-Up Care Through AI by Bringing the Lung Cancer Patient, Data Scientist and Oncologist Together
22. P40.10 Brain Metastases in Patients With Non-Small Cell Lung Cancer Treated With Immunotherapy. Real World Data From a Tertiary Hospital in Spain
23. P31.03 The Impact of the COVID-19 Pandemic on a Thoracic Tumor Unit of a Tertiary Hospital in Spain
24. P54.04 Detecting Elevated Risk of Diminished Quality of Life Among Lung Cancer Patients by Using Wearable Devices
25. OA20.01 Long Term Survival in Operable Stage Iiia Nsclc Patients Treated With Neoadjuvant Nivolumab Plus Chemotherapy - Nadim Study
26. 1168P Clinical characteristics and survival in stage I-IIIA lung cancer resected patients in Spain, analyzed in the Thoracic Tumors Registry (TTR)
27. 1730P Cancer long survivor artificial intelligence follow-up (CLARIFY): Family history of cancer and lung cancer
28. P66.04 Real World Data: Immunotherapy in Lung Cancer Patients over 65 Years Old in Spain
29. Intrathecal baclofen pump exchange in multiple sclerosis. Factors affecting baclofen efficacy and dose adjustement. A case report
30. FP12.01 Circulating Tumor DNA to the Identification of EGFR Positive NSCLC Long-Term Survivors
31. Recambio de bomba intratecal en esclerosis múltiple. Factores que interfieren en la eficacia y ajuste de dosis de baclofeno. A propósito de un caso
32. P09.50 Lung Cancer Hospitalization Burden. Generating Knowledge from Administrative Data to Optimize Management
33. P09.12 SARS- CoV2 Impact in a Spanish Lung Cancer Cohort?
34. P84.16 Treatment Options for Patients with Brain Metastases in Oncogene-Driven Non-Small Cell Lung Cancer
35. P84.14 Identification of Mechanisms of Resistance to ALK Inhibitors. Next-Generation Sequencing-Based Liquid Biopsy Profiling.
36. P25.06 Malignant Pleural Mesothelioma: Patient Characteristics, Treatments and Outcomes from a Spanish Center
37. P52.05 Lung Cancer Symptoms at Diagnosis: Data from the Thoracic Tumors Registry (TTR Study).
38. ES06.01 Neoadjuvant IO Monotherapy vs. Chemo-IO
39. Impact of the growth strategy and device fabrication on the alloy homogeneity in optoelectronic grade Sn-rich GeSn
40. Imagen subdural tras administración de contraste previo a infiltración epidural en paciente con dolor crónico
41. Subdural image after administration of contrast prior to epidural infiltration in a patient with chronic pain
42. 59P Real-world data of immunotherapy in patients over 65 years old with lung cancer
43. 1794P Extensive stage (ES) small-cell lung cancer (SCLC) in Spain: A review of demographic, epidemiological and clinical data from the Thoracic Tumors Registry (TTR study)
44. 1786P Small cell lung cancer (SCLC) extensive stage (ES) in Spain: Efficacy of treatments, data from the thoracic tumours registry (TTR study)
45. Evaluation Through Transcutaneous Tissue Oximetry (Near Infrared Spectroscopy) of Spinal Cord Stimulation in Patients With Complex Regional Pain Syndrome Type I
46. EP1.16-28 ALK Translocated Patients: Survival in an Unselected Population
47. Corrections to “Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis”
48. Prospective study of circulating tumor cells in long survivors of immunotherapy
49. OA01.05 Phase II Study of Neo-Adjuvant Chemo/Immunotherapy for Resectable Stages IIIA Non-Small Cell Lung Cancer- Nadim Study-SLCG
50. P1.15-24 Small Cell Lung Cancer: Clinical Characteristics and Survival of a Spanish Cohort of 221 Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.